SPHK1通过PD-L2 / c-Src / FAK信号级联促进膀癌转移
Wei-Hsiang Kao1,2, Li-Zhu Liao2, Yu-An Chen2,3
1Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
Cell death & disease
|September 16, 2024
概括
斯芬哥辛激酶1型 (SPHK1) 通过激活PD-L2.2,驱动膀癌转移. 一种FDA批准的SPHK1抑制剂FTY720在临床前模型中有效抑制了癌症的扩散.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 类型1 (SPHK1) 类型的氨酸激酶调节脂代谢,并与各种癌症有关.
- 在膀癌的进展和转移中,SPHK1的作用仍然在很大程度上未被探索.
- 了解SPHK1的功能对于开发针对膀癌的向疗法至关重要.
研究的目的:
- 研究SPHK1在膀癌中的临床相关性和机制性作用.
- 为了确定参与膀癌转移的SPHK1的下游点.
- 评估SPHK1抑制在转移性膀癌中的治疗潜力.
主要方法:
- 对癌症基因组图谱 (TCGA) 数据库对SPHK1临床相关性的分析.
- 在膀癌细胞中进行CRISPR/Cas9基因编辑 (淘汰赛和构成性激活).
- 在体外和体内实验中评估SPHK1抑制的效果,使用FTY720.
主要成果:
- SPHK1在膀癌的进展和转移中发挥着重要作用.
- 编程细胞死亡1联体2 (PD-L2) 被确定为SPHK1.1的下游目标.
- SPHK1/S1P信号激活了Akt/β-catenin,促进了PD-L2的诱导,入侵和迁移.
- PD-L2 与c-Src相互作用,进一步激活FAK信号传输.
- SPHK1抑制剂FTY720在抑制膀癌转移方面表现出有效性.
结论:
- 通过SPHK1/S1P/Akt/β-catenin/PD-L2通路,SPHK1是膀癌转移的一个关键驱动因素.
- 用FTY720等抑制剂向SPHK1代表了转移性膀癌的有希望的治疗策略.
- 对SPHK1-PD-L2轴的进一步研究可能会揭示新的治疗途径.
相关概念视频
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


